Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
darolutamide (Nubeqa) (1 trial)
enzalutamide (xtandi) (1 trial)
radium-223 (xofigo) (1 trial)
Prostatic Neoplasms (Phase 3)
Trials (1 total)
Trial APIs (3 total)